Deletion of 18q is a strong and independent prognostic feature in prostate cancer

Deletion of 18q recurrently occurs in prostate cancer. To evaluate its clinical relevance, dual labeling fluorescence in-situ hybridization (FISH) using probes for 18q21 and centromere 18 was performed on a prostate cancer tissue microarray (TMA). An 18q deletion was found in 517 of 6,881 successful...

Descripción completa

Detalles Bibliográficos
Autores principales: Kluth, Martina, Graunke, Maximilian, Möller-Koop, Christina, Hube-Magg, Claudia, Minner, Sarah, Michl, Uwe, Graefen, Markus, Huland, Hartwig, Pompe, Raisa, Jacobsen, Frank, Hinsch, Andrea, Wittmer, Corinna, Lebok, Patrick, Steurer, Stefan, Büscheck, Franziska, Clauditz, Till, Wilczak, Waldemar, Sauter, Guido, Schlomm, Thorsten, Simon, Ronald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349918/
https://www.ncbi.nlm.nih.gov/pubmed/27861151
http://dx.doi.org/10.18632/oncotarget.13404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349918/
https://www.ncbi.nlm.nih.gov/pubmed/27861151
http://dx.doi.org/10.18632/oncotarget.13404

Ejemplares similares